VEEV
NYSE · Health Care
Veeva Systems Inc-Class A
$230.47
+12.67 (+5.82%)
Financial Highlights (FY 2026)
Revenue
2.84B
Net Income
807.25M
Gross Margin
75.5%
Profit Margin
28.4%
Rev Growth
+14.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 75.5% | 75.5% | 58.1% | 58.1% |
| Operating Margin | 28.7% | 25.8% | 7.7% | 8.1% |
| Profit Margin | 28.4% | 27.0% | 8.6% | 7.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 2.84B | 2.49B | 14.30B | 13.12B |
| Gross Profit | 2.14B | 1.88B | 8.31B | 7.62B |
| Operating Income | 813.93M | 642.40M | 1.09B | 1.06B |
| Net Income | 807.25M | 637.14M | 1.23B | 945.93M |
| Gross Margin | 75.5% | 75.5% | 58.1% | 58.1% |
| Operating Margin | 28.7% | 25.8% | 7.7% | 8.1% |
| Profit Margin | 28.4% | 27.0% | 8.6% | 7.2% |
| Rev Growth | +14.0% | +14.0% | +0.9% | -8.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 12.79B | 12.08B |
| Total Equity | — | — | 10.66B | 11.53B |
| D/E Ratio | — | — | 1.20 | 1.05 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 823.11M | 685.74M | 1.77B | 1.57B |
| Free Cash Flow | — | — | 978.68M | 1.27B |